Table 3. Quality assessment of included studies.
| Item/Study | Canbek, 2016 | Chen, 2015 | Gu, 2013 | Jiang, 2017 | Liu, 2016 | Rajasekara, 2015 | Rodriguez, 2008 | Wu, 2014 |
|---|---|---|---|---|---|---|---|---|
| Adequate definition of cases | * | * | * | * | * | * | * | * |
| Representativeness of cases | – | – | * | – | – | – | – | – |
| Selection of control subjects | – | – | – | – | – | – | – | – |
| Definition of control subjects | * | * | * | * | * | * | * | * |
| Control for important factor or additional factor | – | * | * | * | ** | – | – | ** |
| Exposure assessment | * | * | * | * | * | * | * | * |
| Same method of ascertainment for all subjects | * | * | * | * | * | * | * | * |
| Non-response rate | * | * | * | * | * | * | * | * |
A study could be awarded a maximum of one star for each item except for the item ‘Control for important factor or additional factor’.
The definition/explanation of each column of the Newcastle–Ottawa Scale is available from (http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp).